(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TRATAMENTO DA MUCOPOLISSACARIDOSE I COM ALFA-L-IDURONIDASE (IDUS) HUMANA TOTALMENTE HUMANA E GLICOSILADA

ArquivadaInvention PatentPCT · US2019042205

Application data

Number

112021000830

Type

Invention Patent

Filing

07/17/2019

Publication

04/13/2021

PCT

US2019042205

Progress at the INPI

  1. Filing07/17/19
  2. Publication04/13/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 04/24/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

REGENXBIO INC.

US

See this company's full portfolio

Inventors

C. S. (pessoa física)

US

R. R. (pessoa física)

US

S. Y. (pessoa física)

US

Z. W. (pessoa física)

US

Technical data

Priority claims

US

62/699,923 · 07/18/2018

Abstract

TRATAMENTO DA MUCOPOLISSACARIDOSE I COM ALFA-L-IDURONIDASE (IDUS) HUMANA TOTALMENTE HUMANA E GLICOSILADA.São descritas composições e métodos para a distribuição de uma a-L-iduronidase (IDUA) totalmente humana e glicosilada (HuGly) ao líquido cefalorraquidiano do sistema nervoso central (SNC) de um sujeito humano diagnosticado com mucopolissacaridose I (MPS I).

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

04/24/2024

RPI 2781

Parecer de pré-exame

#6.23

01/09/2024

RPI 2766

Alteração de sede deferida

#25.7

01/04/2022

RPI 2661

Notificação de entrada na fase nacional - PCT

#1.3

04/13/2021

RPI 2623

Alteração de dados cadastrais

#1.1

01/26/2021

RPI 2612

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.